You have 9 free searches left this month | for more free features.

Fulvestrant

Showing 1 - 25 of 466

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Breast Cancer, Ovarian Cancer, Liposarcoma Trial (PF-07224826, Fulvestrant)

Not yet recruiting
  • Breast Cancer
  • +5 more
  • (no location specified)
Jun 7, 2023

Treatment Patterns of HR+/HER2- Advanced or Metastatic Breast

Completed
  • HR+/HER2- Advanced or Metastatic Breast Cancer
    • Dublin, Ireland
      Novartis Pharmaceuticals
    May 2, 2023

    Advanced or Metastatic Breast Cancer Trial in Paris (Milademetan, Patient Reported Outcomes (PROs) and Health-Related Quality of

    Not yet recruiting
    • Advanced or Metastatic Breast Cancer
    • Milademetan
    • Patient Reported Outcomes (PROs) and Health-Related Quality of Life (HRQOL)
    • Paris, France
      Institut Curie
    Jun 27, 2023

    Hormone Receptor-positive Advanced Breast Cancer Trial (chidamide,fulvestrant)

    Not yet recruiting
    • Hormone Receptor-positive Advanced Breast Cancer
    • (no location specified)
    Apr 12, 2023

    Premenopausal Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer Trial in Taipei City (Goserelin, Fulvestrant,

    Recruiting
    • Premenopausal Breast Cancer
    • +2 more
    • Taipei City, Taiwan
      Department of Oncology, National Taiwan University Hospital
    Feb 7, 2023

    Breast Cancer Trial (Inavolisib, Fulvestrant, Alpelisib)

    Not yet recruiting
    • Breast Cancer
    • (no location specified)
    Jan 30, 2023

    Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Trial in Ocala (Samuraciclib, Fulvestrant)

    Recruiting
    • Metastatic Breast Cancer
    • +2 more
    • Ocala, Florida
      Ocala Oncology Center PL DBA Florida Cancer Affiliates
    Jul 19, 2023

    Hormone Receptor-positive Advanced Breast Cancer Trial (chidamide combined with fulvestrant)

    Not yet recruiting
    • Hormone Receptor-positive Advanced Breast Cancer
    • chidamide combined with fulvestrant
    • (no location specified)
    Mar 28, 2023

    Metastatic Breast Cancer Trial in Seoul (Fulvestrant plus AI plus ribociclib, AI plus ribociclib)

    Not yet recruiting
    • Metastatic Breast Cancer
    • Fulvestrant plus AI plus ribociclib
    • AI plus ribociclib
    • Seoul, Korea, Republic of
      Korea university Guro hospital
    Apr 16, 2023

    Advanced or Metastatic Breast Cancer Trial (PF-07220060, Fulvestrant, Everolimus)

    Not yet recruiting
    • Advanced or Metastatic Breast Cancer
    • (no location specified)
    Oct 24, 2023

    Breast Cancer Trial ([68Ga]Ga-NeoB, [177Lu]Lu-NeoB, Ribociclib)

    Not yet recruiting
    • Breast Cancer
    • (no location specified)
    May 22, 2023

    Breast Cancer Trial in Marseille (M1774, Fulvestrant injection)

    Not yet recruiting
    • Breast Cancer
    • Marseille, France
      Institut Paoli Calmettes
    Aug 9, 2023

    Breast Cancer Stage IV Trial in Nice, Villejuif (Alpelisib, Ribociclib)

    Not yet recruiting
    • Breast Cancer Stage IV
    • Nice, France
    • +1 more
    Nov 14, 2022

    Breast Cancer Trial in Tianjin (Dalpiciclib, Pyrotinib, Fulvestrant)

    Not yet recruiting
    • Breast Cancer
    • Tianjin, China
      Tianjin Cancer Hospital
    Mar 28, 2023

    Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer Trial (Giredestrant, Fulvestrant, Abemaciclib)

    Not yet recruiting
    • Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
    • (no location specified)
    Sep 26, 2023

    Malignant Tumors of Female Genital Organs Trial in Houston (Fulvestrant, Abemaciclib)

    Active, not recruiting
    • Malignant Neoplasms of Female Genital Organs
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Dec 5, 2022

    Breast Cancer Trial in Shanghai (Dalpiciclib, Fulvestrant, Pertuzumab)

    Active, not recruiting
    • Breast Cancer
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Oct 10, 2022

    Metastatic Breast Cancer Trial (Lasofoxifene in combination with abemaciclib, Fulvestrant in combination with abemaciclib)

    Not yet recruiting
    • Metastatic Breast Cancer
    • Lasofoxifene in combination with abemaciclib
    • Fulvestrant in combination with abemaciclib
    • (no location specified)
    Jan 25, 2023

    Metastatic Breast Cancer Trial in United States (Lenvatinib, Pembrolizuma, Fulvestrant)

    Not yet recruiting
    • Metastatic Breast Cancer
    • Basking Ridge, New Jersey
    • +6 more
    Oct 31, 2023

    Advanced Breast Cancer Trial in Seoul (Olaparib, Fulvestrant)

    Not yet recruiting
    • Advanced Breast Cancer
    • Seoul, Korea, Republic of
      Seoul National University Hospital
    Sep 12, 2022

    Breast Cancer Trial in Shanghai (Chidamide, Abemaciclib, Fulvestrant)

    Recruiting
    • Breast Cancer
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Jul 31, 2022

    Breast Cancer Trial in Shanghai (HS-10352 combined with fulvestrant (Stage 1), HS-10352 combined with fulvestrant (Stage 2))

    Recruiting
    • Breast Cancer
    • HS-10352 combined with fulvestrant (Stage 1)
    • HS-10352 combined with fulvestrant (Stage 2)
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Aug 15, 2022

    Metastatic Breast Cancer Trial in Amman (Fulvestrant injection)

    Completed
    • Metastatic Breast Cancer
    • Fulvestrant injection
    • Amman, Jordan
      Triumpharma Cro
    Oct 3, 2023

    Advanced Breast Cancer Trial in Thalassery (Alpelisib, Fulvestrant)

    Recruiting
    • Advanced Breast Cancer
    • Thalassery, Kerala, India
      Novartis Investigative Site
    Nov 21, 2022

    Endometrial Cancer, Ovarian Cancer Trial in Houston (Copanlisib, fulvestrant)

    Recruiting
    • Endometrial Cancer
    • Ovarian Cancer
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 27, 2022